Pregnancy Clinical Trial
Official title:
EMBRACE MOMS 2 BE: A Pilot Feasibility, Acceptability, and Preliminary Efficacy Study of a Mindful Eating Self-Help Program for Women Who Binge Eat During Pregnancy
Verified date | May 2023 |
Source | University of North Carolina, Charlotte |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Primary Study Aims: 1. To evaluate the feasibility, acceptability, and preliminary efficacy of a 10-week mindful eating self-help program for women who binge eat during pregnancy. Primary efficacy targets will include measures of mindful eating and binge eating. Secondary efficacy targets will involve measures of body image and well-being. 2. To evaluate the incremental utility of adding use of a companion mindful eating smart phone application for enhancing the acceptability and preliminary efficacy of the program. 3. To gain insights into ways in which this program may be better tailored to the experiences of pregnancy for future program adaptation and refinement.
Status | Suspended |
Enrollment | 50 |
Est. completion date | September 2024 |
Est. primary completion date | June 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 40 Years |
Eligibility | Inclusion Criteria: - female (assigned sex at birth) - able to read and write in English - between the ages of 18-40 - lives in the United States - between 13-16 weeks pregnant (gestation) with a singleton - owns an iPhone or iPad - reports engaging in recurrent binge eating (i.e., reporting engaging in at least 1 binge eating episode per week for the last 28 days according to the EDE-Qi) - has access to a computer or tablet with Internet - being regularly followed by a healthcare provider during their pregnancy Exclusion Criteria: - reports current smoking or substance abuse - reports elevated depression (i.e., a score of 13 or higher on the EPDS) - reports current suicidal ideation (assessed on the EPDS) - reports anorexia, purging or compensatory behavior (both assessed on the EDE-Qi) - reports a history of being hospitalized for mental health treatment in the last 6 months - reports use of medications that are taken to affect appetite or metabolism (e.g., insulin) - is currently in therapy for treating binge eating - reports serious cardiovascular morbidity (e.g., hypertension) - reports uncontrolled or untreated thyroid disease - reports a history of 3 or more miscarriages, weakened cervix, or persistent bleeding during the first 12 weeks of pregnancy - reports being unable to commit to participate fully in the 10-week program (i.e., read from the self-help book weekly, utilize the smartphone application daily, submit weekly logs of their experiences) - individuals seeking a dieting approach to weight management during pregnancy |
Country | Name | City | State |
---|---|---|---|
United States | UNC Charlotte | Charlotte | North Carolina |
Lead Sponsor | Collaborator |
---|---|
University of North Carolina, Charlotte |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Enrollment | percent enrollment within 6 months of opening recruitment | 6 months after opening enrollment | |
Primary | Attrition | percent of participants who dropped out | throughout the 10-week program | |
Primary | Program Satisfaction | participant satisfaction questionnaire | after week 10 | |
Primary | App Usability | app usability questionnaire | after week 10 | |
Primary | Mindful Eating | Mindful Eating Inventory (MEI) | baseline, after week 5 (midpoint), after week 10 (immediate post) | |
Primary | Binge Eating | Eating Disorders Examination-Questionnaire with Instructions (EDE-Qi) | baseline, after week 5 (midpoint), after week 10 (immediate post) | |
Primary | Intuitive Eating | Intuitive Eating Scale-2 (IES-2) | baseline, after week 5 (midpoint), after week 10 (immediate post) | |
Secondary | Body Image | Body Image in Pregnancy Scale (BIPS) | baseline, after week 5 (midpoint), after week 10 (post-program) | |
Secondary | General Well-being | General Well-being: Warwick-Edinburgh Mental Well-being Scale (WEMWBS) | baseline, after week 5 (midpoint), after week 10 (post-program) | |
Secondary | COVID-19-related Well-being | Perinatal COVID-19-related Well-being (COPE-IU) | baseline, after week 5 (midpoint), after week 10 (post-program) | |
Secondary | Mindful Self-Care | Mindful Self-Care Scale (MSCS) | baseline, after week 5 (midpoint), after week 10 (immediate post) | |
Secondary | Weight Bias Internalization | Weight Bias Internalization Scale-Modified (WBIS-M) | baseline, after week 5 (midpoint), after week 10 (immediate post) | |
Secondary | Physical Activity | International Physical Activity Questionnaire-Short Form (IPAQ-SF) | baseline, after week 5 (midpoint), after week 10 (immediate post) | |
Secondary | Depression | Edinburgh Postnatal Depression Scale (EPDS) | baseline, after week 5 (midpoint), after week 10 (immediate post) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Completed |
NCT02528136 -
The Clinical Carbetocin Myocardium Trial
|
Phase 4 |